European Federation of Pharmaceutical Industries and Associations: meetings with the Commission
Meetings 1–50 of 51, newest first. Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them
Public records onlyWhat this means
Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself
Registering is a legal transparency duty, not a sign of wrongdoing. Budgets and meetings show access, not influence on any particular decision
With the Cabinet
Published recordSafe Hearts Plan and EU Screening Week
With the Cabinet
Published recordPreventive health and early detection
With the Commissioner
Published recordPFAS clean-up High Level dialogue
With the Cabinet
Published recordPFAS clean-up High Level dialogue
With the Commissioner
Published recordHealth industry roundtable
With the Cabinet
Published recordHealth industry roundtable
With the Commissioner
Published recordCurrent pharma affairs
With the Cabinet
Published recordCurrent pharma affairs
With the Commissioner
Published recordHealth industry roundtable
With the Cabinet
Published recordHealth industry roundtable
With the Commissioner
Published recordInternational context of the pharmaceutical industry
With the Cabinet
Published recordInternational context of the pharmaceutical industry
With the Commissioner
Published recordBiotech Act, Pharma package, CMA
With the Cabinet
Published recordEnvironmental legislation
With the Commissioner
Published recordFuture of European pharmaceuticals sector
With the Cabinet
Published recordFuture of European pharmaceuticals sector
With the Commissioner
Published recordLife sciences
With the Cabinet
Published recordLife sciences
With the Cabinet
Published recordRoundtable on Simplification for Pharmaceutical Innovation
With the Cabinet
Published recordEU – US relations
With the Commissioner
Published recordAll pressing portfolio topics
With the Cabinet
Published recordAll pressing portfolio topics
With the Commissioner
Published recordSite visit of UCB factory
With the Commissioner
Published recordConsumer protection dimension of specific dossiers
With the Cabinet
Published recordSite visit of UCB factory
With the Cabinet
Published recordConsumer protection dimension of specific dossiers
With the Commissioner
Published recordTo discuss the REACH revision and discuss the IHI PFAS projects.
With the Cabinet
Published recordTo discuss the REACH revision and discuss the IHI PFAS projects.
With the Commissioner
Published recordExchange of views on the EU pharma policy
With the Cabinet
Published recordExchange of views on the EU pharma policy
With the Cabinet
Published recordCompetitiveness and simplification
With the Cabinet
Published recordDiscussion on the pharmaceutical industry Strategic Dialogue
With the Commissioner
Published recordExchange of views on the EU pharma policy
With the Cabinet
Published recordExchange of views on the EU pharma policy
With the Cabinet
Published record- potential U.S. tariffs on Pharma - upcoming REACH revision and PFAS - European environmental legislation
With the Commissioner
Published recordImpact of US tariffs
With the Cabinet
Published recordImpact of US tariffs
With the Cabinet
Published recordFinancing challenges for small enterprises
With the Cabinet
Published recordCompetitiveness of the EU pharmaceutical industry
With the Commissioner
Published recordExchange of views on the EU health policy
With the Cabinet
Published recordExchange of views on the EU health policy
With the Commissioner
Published recordGlobal trade developments and challenges
With the Cabinet
Published recordGlobal trade developments and challenges
With the Commissioner
Published recordTopical issues for the pharmaceutical industry, including competitiveness and skills.
With the Cabinet
Published recordTopical issues for the pharmaceutical industry, including competitiveness and skills.
With the Cabinet
Published recordtaxonomy
With the Commissioner
Published recordMeeting with EFPIA’s Board members on the objectives of the new Commission to build a cleaner and more competitive Europe.
With the Cabinet
Published recordMeeting with EFPIA’s Board members on the objectives of the new Commission to build a cleaner and more competitive Europe.
With the Cabinet
Published recordChemical Regulation & Water Treatment Directive
With the Cabinet
Published recordhealth policies -priorities
Checked against sources on 11 Nov 2026